Study on the Chronic and Acute Effects of Nordic Berry Beverage on Cognitive Function
NCT ID: NCT05693441
Last Updated: 2023-07-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2023-01-17
2023-06-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment
NCT04317612
Effects of Berries and Vegetables on Cardiometabolic Risk Markers and Cognitive Functions
NCT01562392
Anthocyanins as Dementia Prevention?
NCT03419039
Effect of Coffeeberry on Mood, Motivation and Cognitive Performance
NCT04974606
The Acute Effect of Two Berry Extracts on Cognition and Mood in Adults Aged 40 to 60
NCT02810769
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Two groups, each of 30 volunteers, are studied. One group of volunteers will consume the berry product while the other group act as control and will consume the reference product.
Each volunteer will be seen for a screening visit as well as one pre- and one post-intervention visit at the clinic. In addition, there will be 2 follow-up calls in between visits. Pre- and post intervention visits will include cognitive assessment with the CANTAB battery (episodic memory and verbal recognition memory), as well as additional cognitive and behavioral tests. Cardiometabolic parameters will be addressed (plasma glucose, insulin, inflammatory markers, blood lipids, body composition) and fecal samples collected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active berry product
Once daily consumption over the period of the study
Active berry product
Subjects should consume the active product containing nordic berries daily during the 12 week intervention period.
Reference berry-like product
Once daily consumption over the period of the study
Reference berry-like product
Subjects should consume a reference product (isocaloric to active product, containing berry aromas and colouring but no actual berry compounds) daily during the 12 week intervention period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active berry product
Subjects should consume the active product containing nordic berries daily during the 12 week intervention period.
Reference berry-like product
Subjects should consume a reference product (isocaloric to active product, containing berry aromas and colouring but no actual berry compounds) daily during the 12 week intervention period.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Capable and willing to give written informed consent.
3. Capable and willing to perform cognitive testing in Swedish (mastering the Swedish language, functional vision and hearing or the use of visual or hearing aids during testing).
4. Capable and willing to ingest the study beverage for 12 weeks and to follow the instructions given.
5. Agree to maintain consistent dietary habits and physical activity levels for the duration of the study
Exclusion Criteria
2. Affected by other medical condition(s) or medication(s) known to significantly affect cognitive function.
3. Past history of brain damage, significant head trauma (including loss of consciousness as a result), brain surgery or stroke.
4. Underweight (BMI \<18.5).
5. Significant psychiatric disorders with current symptoms.
6. Type 1 diabetes, recently diagnosis of Type 2 diabetes (\<12 months) or ongoing insulin treatment.
7. Ongoing treatment for malignancy\*.
8. Significant change in medication over the last 3 months.
9. Undergoing antibiotic therapy for the last 3 months prior to inclusion in the study.
10. Blood donation before (3 months) or during the study period.
11. Planned major intervention in health care or change in medication over the next 3 months (study period).
12. Currently active smoker or regular use of other nicotine products.
13. Drug or alcohol abuse.
14. Conditions with major impact on the gastrointestinal tract (such as Crohn's disease, ulcerative colitis, diagnosed gluten intolerance, undertaken intestinal resection or weight loss surgery).
15. Allergy / intolerance to berries or other ingredients in the study products (i.e., colorants, aromas, starch).
16. Vegetarians / vegans.
17. Daily, regular high consumption (approximately 1 dl or more per day) of berries or juices / marmalade / products with high content of bilberries and lingonberries. (Can be recruited if consumption has ceased to less than 5 grams of berries per day at least 1 month before visit 1.).
18. Taking supplements with potential cognitive effects (e.g., omega-3, ginko biloba, Souvenaid), or containing grape and berry extracts or probiotics (capsules or ProViva). (Can be recruited if this intake ceases at least one month before visit 1).
19. Planned longer absence/vacation during the next 3 months (study period).
20. Sharing household with someone participating in the current study
21. Concurrent participation in other clinical intervention trials (dietary/pharmacological).
60 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Berry Lab AB
UNKNOWN
Aventure AB
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aventure AB
Lund, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCANBerry2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.